Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Trial of Aspirin for Recurrence and Survival in Colon Cancer
2011-004686-32Phase 3Active
- Sponsor
- Leiden University Medical Center
- Start
- Jun 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in colon adenocarcinoma comparing Aspirin arm with Placebo arm (2 arms). Primary endpoint: 5-year overall survival. Started Jun 2014; status: active.
02
Drugs
aspirin
03
Conditions
colon adenocarcinoma
Beyond the preview
Go deeper on 2011-004686-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004686-32.